PaxMedica (PXMD) News Today $0.12 0.00 (0.00%) (As of 11/4/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD PatientsSeptember 23, 2024 | msn.comBioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884KSeptember 3, 2024 | msn.comYale Study Unravels Autism, Brain Growth PatternsSeptember 1, 2024 | msn.comPaxMedica, Inc.: PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness InfectionAugust 27, 2024 | finanznachrichten.dePaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101May 15, 2024 | globenewswire.comPXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024May 14, 2024 | investorplace.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 7, 2024 | markets.businessinsider.comPaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory StrategyMay 7, 2024 | finance.yahoo.comPaxMedica (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDAMay 3, 2024 | theglobeandmail.comPaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell PodcastApril 26, 2024 | finance.yahoo.comUrgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in MalawiApril 25, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDAApril 25, 2024 | theglobeandmail.comPaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101April 23, 2024 | globenewswire.comPaxMedica, Inc.: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping SicknessApril 18, 2024 | finanznachrichten.dePaxMedica, Inc.: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 12, 2024 | finanznachrichten.deNasdaq Down 300 Points; BlackRock Posts Upbeat EarningsApril 12, 2024 | markets.businessinsider.comPenny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock RalliesApril 12, 2024 | msn.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 12, 2024 | investorplace.comWhy Is PaxMedica (PXMD) Stock Up 93% Today?April 12, 2024 | investorplace.comPaxMedica shares soar 125% post-market on drug updateApril 11, 2024 | msn.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 11, 2024 | finance.yahoo.comPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA SubmissionApril 11, 2024 | globenewswire.comPaxMedica (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated ConditionsApril 9, 2024 | theglobeandmail.comPaxMedica (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD PatientsMarch 23, 2024 | theglobeandmail.comPaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder TreatmentsMarch 13, 2024 | globenewswire.comPaxMedica Inc Ordinary Shares PXMDMarch 6, 2024 | morningstar.comPaxMedica Stock (NASDAQ:PXMD), Short Interest ReportFebruary 23, 2024 | benzinga.comPaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASDJanuary 29, 2024 | theglobeandmail.comIBN Highlights PaxMedica's Video Release on Transformative ASD StudyJanuary 18, 2024 | finance.yahoo.comIBN Highlights PaxMedica’s (NASDAQ: PXMD) Video Release on Transformative ASD StudyJanuary 17, 2024 | theglobeandmail.comPaxMedica on Promising Path to Address Unmet ASD NeedsJanuary 17, 2024 | finance.yahoo.comPaxMedica Files 8-K Following Nasdaq Compliance AchievementDecember 22, 2023 | finance.yahoo.comPaxMedica, Inc. (PXMD) Interactive Stock Chart - Yahoo FinanceDecember 20, 2023 | finance.yahoo.comPaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy PipelineDecember 19, 2023 | finance.yahoo.comPaxMedica Inc. Covered in H.C. Wainwright & Co. Research ReportDecember 12, 2023 | finance.yahoo.comPaxMedica CEO Featured in Just-Released Fireside Chat VideoDecember 8, 2023 | finance.yahoo.comPaxMedica Releases Fireside Chat Video with CEO Howard WeismanDecember 6, 2023 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy RecommendationDecember 5, 2023 | msn.comPaxMedica Stock (NASDAQ:PXMD), Analyst Ratings, Price Targets, PredictionsDecember 4, 2023 | benzinga.comPaxMedica Closes on Public Offering Reaching Estimated $7MDecember 1, 2023 | finance.yahoo.comPaxMedica Announces Closing of $7.0 Million Public OfferingNovember 25, 2023 | finance.yahoo.comPaxMedica, Inc.: PaxMedica Announces Closing of $7.0 Million Public OfferingNovember 22, 2023 | finanznachrichten.dePaxMedica Announces Pricing of $7M Public OfferingNovember 22, 2023 | finance.yahoo.comWhy Is PaxMedica (PXMD) Stock Up 57% Today?November 22, 2023 | investorplace.comPaxMedica News of FDA Type-B Meeting Shared in Audio BroadcastNovember 21, 2023 | finance.yahoo.comWhy Is PaxMedica (PXMD) Stock Down 40% Today?November 20, 2023 | investorplace.comPaxMedica, Inc.: PaxMedica Announces Pricing of $7.0 Million Public OfferingNovember 20, 2023 | finanznachrichten.deCrude Oil Gains Over 2%; PaxMedica Shares PlungeNovember 20, 2023 | markets.businessinsider.comWhy PaxMedica Stock (PXMD) Is Down Nearly 40% TodayNovember 20, 2023 | msn.comPaxMedica Announces Pricing of $7.0 Million Public OfferingNovember 20, 2023 | finance.yahoo.com Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW PXMD Media Mentions By Week PXMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMD News Sentiment▼0.000.46▲Average Medical News Sentiment PXMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMD Articles This Week▼01▲PXMD Articles Average Week Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies JAGX News BMRA News VRAX News ONCT News ADIL News CDIO News ERNA News NCNA News BFRI News GOVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PXMD) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXMD Stock Alerts